Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and Yi Xue An Granules. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.
Essex Bio-Technology Dividend Announcement
• Essex Bio-Technology announced a semi annually dividend of HK$0.06 per ordinary share which will be made payable on 2024-09-24. Ex dividend date: 2024-09-09
• Essex Bio-Technology annual dividend for 2024 was HK$0.10
• Essex Bio-Technology annual dividend for 2023 was HK$0.07
• Essex Bio-Technology's trailing twelve-month (TTM) dividend yield is 4.02%
• Essex Bio-Technology's payout ratio for the trailing twelve months (TTM) is 19.47%
• Essex Bio-Technology's dividend growth over the last five years (2018-2023) was 4.94% year
• Essex Bio-Technology's dividend growth over the last ten years (2013-2023) was 21.48% year
Essex Bio-Technology Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-09 | HK$0.06 | semi annually | 2024-09-24 |
2024-05-30 | HK$0.04 | semi annually | 2024-06-17 |
2023-08-29 | HK$0.04 | semi annually | 2023-09-13 |
2023-06-13 | HK$0.03 | semi annually | 2023-06-29 |
2022-09-05 | HK$0.04 | semi annually | 2022-09-21 |
2022-05-04 | HK$0.06 | semi annually | 2022-05-20 |
2021-08-30 | HK$0.04 | semi annually | 2021-09-14 |
2021-05-14 | HK$0.05 | semi annually | 2021-06-01 |
2020-05-14 | HK$0.05 | semi annually | 2020-06-02 |
2019-08-29 | HK$0.04 | semi annually | 2019-09-20 |
2019-05-03 | HK$0.03 | semi annually | 2019-05-27 |
2018-09-03 | HK$0.03 | semi annually | 2018-09-21 |
2018-05-15 | HK$0.03 | semi annually | 2018-06-01 |
2017-09-28 | HK$0.03 | semi annually | 2017-10-20 |
2017-05-09 | HK$0.03 | semi annually | 2017-05-26 |
2016-05-11 | HK$0.03 | semi annually | 2016-05-27 |
2015-05-13 | HK$0.02 | semi annually | 2015-05-27 |
2014-05-12 | HK$0.02 | semi annually | 2014-05-26 |
2013-05-09 | HK$0.01 | semi annually | 2013-05-27 |
Essex Bio-Technology Dividend per year
Essex Bio-Technology Dividend growth
Essex Bio-Technology Dividend Yield
Essex Bio-Technology current trailing twelve-month (TTM) dividend yield is 4.02%. Interested in purchasing Essex Bio-Technology stock? Use our calculator to estimate your expected dividend yield:
Essex Bio-Technology Financial Ratios
Essex Bio-Technology Dividend FAQ
Other factors to consider when evaluating Essex Bio-Technology as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Essex Bio-Technology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Essex Bio-Technology's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Essex Bio-Technology publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Essex Bio-Technology distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Essex Bio-Technology are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Essex Bio-Technology sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Essex Bio-Technology distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Essex Bio-Technology declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Essex Bio-Technology's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Essex Bio-Technology's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.